Founders Grove Wealth Partners, LLC Abb Vie Inc. Transaction History
Founders Grove Wealth Partners, LLC
- $426 Billion
- Q3 2025
A detailed history of Founders Grove Wealth Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Founders Grove Wealth Partners, LLC holds 2,473 shares of ABBV stock, worth $578,682. This represents 0.13% of its overall portfolio holdings.
Number of Shares
2,473
Previous 2,387
3.6%
Holding current value
$578,682
Previous $443 Million
29.23%
% of portfolio
0.13%
Previous 0.11%
Shares
3 transactions
Others Institutions Holding ABBV
# of Institutions
4,489Shares Held
1.28BCall Options Held
16.9MPut Options Held
15.2M-
Vanguard Group Inc Valley Forge, PA178MShares$41.6 Billion0.64% of portfolio
-
Black Rock Inc. New York, NY136MShares$31.9 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.8MShares$18.7 Billion0.66% of portfolio
-
Jpmorgan Chase & CO New York, NY56.5MShares$13.2 Billion0.86% of portfolio
-
Morgan Stanley New York, NY41.7MShares$9.75 Billion0.61% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $414B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...